Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
95.8M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
15.1M
-
Shares change
-
-3.25M
-
Total reported value, excl. options
-
$22.6M
-
Value change
-
-$4.81M
-
Put/Call ratio
-
0.42
-
Number of buys
-
16
-
Number of sells
-
-22
-
Price
-
$1.50
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q4 2023
62 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q4 2023.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.1M shares
of 95.8M outstanding shares and own 15.71% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.34M shares), Gratus Capital LLC (1.94M shares), Omega Fund Management, LLC (1.79M shares), VANGUARD GROUP INC (1.69M shares), UBS OCONNOR LLC (600K shares), ACADIAN ASSET MANAGEMENT LLC (559K shares), Logos Global Management LP (421K shares), GEODE CAPITAL MANAGEMENT, LLC (418K shares), BlackRock Inc. (362K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (335K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.